On this page
Vowst
fecal microbiota spores, live-brpk
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Vowst
Proper name
fecal microbiota spores, live-brpk
Licence type
351(a)
BLA number
125757
Applicant
Aimmune Therapeutics, Inc.
Center
CBER
Presentations
1
First licensure
April 26, 2023
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 1X10 LOG 6 AND 3X10 LOG 7CFU/TAB | Capsule | Oral | Bottle | Rx | April 26, 2023 |
Exclusivity
Source: Purple Book| Kind | Expires |
|---|---|
| Orphan exclusivity | April 26, 2030 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |